应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01358 普华和顺
收市竞价 10-08 16:08:37
0.910
+0.020
+2.25%
最高
0.925
最低
0.900
成交量
194.20万
今开
0.900
昨收
0.890
日振幅
2.81%
总市值
13.04亿
流通市值
13.04亿
总股本
14.33亿
成交额
176.93万
换手率
0.14%
流通股本
14.33亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
普华和顺更新2026年9月股份变动月报表,股本维持稳定
公告速递 · 10-07 17:00
普华和顺更新2026年9月股份变动月报表,股本维持稳定
普华和顺回购65万股,耗资约61.04万港元
公告速递 · 09-30
普华和顺回购65万股,耗资约61.04万港元
普华和顺回购59.3万股股份,耗资约54.85万港元
公告速递 · 09-29
普华和顺回购59.3万股股份,耗资约54.85万港元
普华和顺(01358)9月29日斥资54.8万港元回购59.3万股
智通财经 · 09-29
普华和顺(01358)9月29日斥资54.8万港元回购59.3万股
普华和顺(01358)全资子公司徐州一佳启动破产清算并实施财产变价方案
公告速递 · 09-28
普华和顺(01358)全资子公司徐州一佳启动破产清算并实施财产变价方案
普华和顺2026年中期财报营收3.94亿元,经调整净利润68.65百万元
公告速递 · 09-21
普华和顺2026年中期财报营收3.94亿元,经调整净利润68.65百万元
普华和顺9月11日回购10.60万股,耗资约10.31万港元
公告速递 · 09-11
普华和顺9月11日回购10.60万股,耗资约10.31万港元
普华和顺:9月10日回购70万股股份,总涉资约68.12万港元
公告速递 · 09-10
普华和顺:9月10日回购70万股股份,总涉资约68.12万港元
普华和顺(01358)9月10日耗资约68.12万港元回购70万股
智通财经 · 09-10
普华和顺(01358)9月10日耗资约68.12万港元回购70万股
普华和顺回购40.2万股股份,耗资约39.03万港元
公告速递 · 09-09
普华和顺回购40.2万股股份,耗资约39.03万港元
普华和顺(01358)9月8日斥资4.85万港元回购5万股
智通财经 · 09-08
普华和顺(01358)9月8日斥资4.85万港元回购5万股
普华和顺回购5万股股份,总额约4.85万港元
公告速递 · 09-08
普华和顺回购5万股股份,总额约4.85万港元
普华和顺回购7.8万股股份,总额约7.47万港元
公告速递 · 09-07
普华和顺回购7.8万股股份,总额约7.47万港元
普华和顺(01358.HK)9月7日斥资约7.47万港元回购7.8万股
智通财经 · 09-07
普华和顺(01358.HK)9月7日斥资约7.47万港元回购7.8万股
普华和顺再度回购10万股股份,涉资约9.50万港元
公告速递 · 09-04
普华和顺再度回购10万股股份,涉资约9.50万港元
普华和顺(01358)9月4日斥资9.5万港元回购10万股
智通财经 · 09-04
普华和顺(01358)9月4日斥资9.5万港元回购10万股
普华和顺回购19.6万股股份,总额约18.24万港元
公告速递 · 09-03
普华和顺回购19.6万股股份,总额约18.24万港元
普华和顺更新8月股份变动月报表,股本维持稳定
公告速递 · 09-03
普华和顺更新8月股份变动月报表,股本维持稳定
普华和顺回购47.3万股股份,涉资约43.14万港元
公告速递 · 09-02
普华和顺回购47.3万股股份,涉资约43.14万港元
普华和顺(01358)9月2日斥资43.14万港元回购47.3万股
智通财经 · 09-02
普华和顺(01358)9月2日斥资43.14万港元回购47.3万股
加载更多
公司概况
公司名称:
普华和顺
所属市场:
SEHK
上市日期:
--
主营业务:
普华和顺集团公司是一家主要从事医疗器械的研发(R&D)及销售业务的投资控股公司。该公司通过三个分部开展业务。输液器业务分部主要从事输液器、静脉留置针产品、胰岛素针等的研发、制造及销售。血液净化业务分部主要从事血液透析及血液净化医疗器械的研发、制造及销售。再生医用生物材料业务分部主要从事动物源性组织再生医用生物材料及人体组织修复替代产品的研发及制造。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01358","market":"HK","secType":"STK","nameCN":"普华和顺","latestPrice":0.91,"timestamp":1791446895533,"preClose":0.89,"halted":0,"volume":1942000,"delay":0,"changeRate":0.02247191011235957,"floatShares":1433000000,"shares":1433000000,"eps":0.0625,"marketStatus":"收市竞价","change":0.02,"latestTime":"10-08 16:08:37","open":0.9,"high":0.925,"low":0.9,"amount":1769280,"amplitude":0.02809,"askPrice":0.915,"askSize":89000,"bidPrice":0.91,"bidSize":99000,"shortable":0,"etf":0,"ttmEps":0.034209477,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791447000000},"marketStatusCode":4,"adr":0,"listingDate":1383840000000,"exchange":"SEHK","adjPreClose":0.89,"dividendRate":0.034524,"openAndCloseTimeList":[[1791423000000,1791432000000],[1791435600000,1791446400000]],"volumeRatio":7.786688,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01358","defaultTab":"news","newsList":[{"id":"1126037519","title":"普华和顺更新2026年9月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1126037519","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126037519?lang=zh_cn&edition=full","pubTime":"2026-10-07 17:00","pubTimestamp":1791363651,"startTime":"0","endTime":"0","summary":"普华和顺于2026年10月7日发布了截至2026年9月30日的证券变动月报表。公告显示,公司法定股本维持在5,000,000,000股普通股,面值为每股0.0001美元,注册股本合计500,000美元,较上月无变动。截至9月末,已发行股份总数保持不变。公告同时提及公司曾于2026年6月26日购回5,763,000股普通股,但该部分股份尚未注销,因而在本月未对发行股数形成影响。公告未披露当月任何股份期权或股权激励相关变动。本次月报由公司董事张月娥签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125271567","title":"普华和顺回购65万股,耗资约61.04万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125271567","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125271567?lang=zh_cn&edition=full","pubTime":"2026-09-30 18:32","pubTimestamp":1790764339,"startTime":"0","endTime":"0","summary":"2026年9月30日,普华和顺集团公司在香港联合交易所公告,称当日于联交所场内回购普通股650,000股,约占该公司已发行股本的0.0454%。本次回购价格介乎每股0.93港元至0.94港元,合计耗资610,375港元。公告显示,本次回购完成后,公司已发行股本仍为1,433,241,098股,库藏股数量为零。公司于2026年6月26日通过购回授权,允许回购最高合计144,285,509股。公司表示,回购行为已遵守香港联交所证券上市规则及相关法律法规。本公告由公司董事张月娥签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺回购65万股,耗资约61.04万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117168240","title":"普华和顺回购59.3万股股份,耗资约54.85万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117168240","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117168240?lang=zh_cn&edition=full","pubTime":"2026-09-29 19:21","pubTimestamp":1790680892,"startTime":"0","endTime":"0","summary":"普华和顺(股票代码:01358)于2026年9月29日发布翌日披露报表。公告显示,公司当日于香港联交所场内回购股份59.3万股,占公司已发行股本约0.0414%,回购价格介乎每股0.92港元至0.93港元,涉资合计约54.85万港元。此次回购尚未导致公司已发行股本变动,其截至2026年9月29日的已发行股本总数仍为约14.33亿股,且并无持有库藏股份。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺回购59.3万股股份,耗资约54.85万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671167952","title":"普华和顺(01358)9月29日斥资54.8万港元回购59.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671167952","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671167952?lang=zh_cn&edition=full","pubTime":"2026-09-29 19:20","pubTimestamp":1790680858,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布公告,于2026年9月29日斥资54.8万港元回购59.3万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169036017","title":"普华和顺(01358)全资子公司徐州一佳启动破产清算并实施财产变价方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1169036017","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169036017?lang=zh_cn&edition=full","pubTime":"2026-09-28 20:20","pubTimestamp":1790598047,"startTime":"0","endTime":"0","summary":"普华和顺集团公司9月28日晚间公告称,其间接全资子公司徐州一佳医疗器械有限公司已进入破产清算程序,并在首次债权人会议上获通过《财产变价方案》,后续将通过网拍等方式处置全部资产。2025年8月,徐州一佳向中国法院申请破产清算并获受理,法院已委任管理人负责清算工作。2026年9月11日,徐州一佳召开第一次债权人会议;9月28日,管理人宣布债权人会议已通过财产变价方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185450947","title":"普华和顺2026年中期财报营收3.94亿元,经调整净利润68.65百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185450947","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185450947?lang=zh_cn&edition=full","pubTime":"2026-09-21 19:21","pubTimestamp":1789989706,"startTime":"0","endTime":"0","summary":"截至2026年6月30日止六个月,普华和顺实现营收3.94亿元,同比下降4.9%。同期经调整净利润为68.65百万元,同比下降42.4%。报告期内毛利为189.90百万元,同比下降10.8%,毛利率为48.2%。此外,销售及市场推广开支为42.58百万元,同比下降2.7%,一般及行政开支为93.45百万元,同比上涨12.0%,研发投入为25.70百万元,同比上升14.3%。展望显示,普华和顺将继续加强研发投入与创新,优化产品矩阵与经营管理效率,并持续提升经营韧性,以在行业结构调整中捕捉新的发展机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"普华和顺2026年中期财报营收3.94亿元,经调整净利润68.65百万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182700215","title":"普华和顺9月11日回购10.60万股,耗资约10.31万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1182700215","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182700215?lang=zh_cn&edition=full","pubTime":"2026-09-11 19:12","pubTimestamp":1789125123,"startTime":"0","endTime":"0","summary":"普华和顺集团公司2026年9月11日发布翌日披露报表,公告当日于香港联交所场内回购普通股10.60万股,占公司已发行股份总数的0.0074%。回购价格介乎每股0.97港元至0.975港元,合计支出约10.31万港元。回购完成后,公司已发行股份仍为1,433,241,098股,库藏股数为0。根据公告,此次回购基于公司于2026年6月26日通过的购回授权,授权可回购股份总数为144,285,509股。至今累计回购股份4,520,000股,占授权决议通过当日已发行股本约0.3133%。本公告由公司董事张月娥签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺9月11日回购10.60万股,耗资约10.31万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147931055","title":"普华和顺:9月10日回购70万股股份,总涉资约68.12万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1147931055","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147931055?lang=zh_cn&edition=full","pubTime":"2026-09-10 19:40","pubTimestamp":1789040458,"startTime":"0","endTime":"0","summary":"普华和顺(01358)于2026年9月10日发布翌日报表,披露当日于香港联交所场内回购普通股70万股,占当日已发行股本约0.0488%。每股回购价介乎每股0.965港元至0.98港元,合计涉资约68.12万港元(约681,245.00港元)。该批股份暂未注销,公司已发行股本仍为1,433,241,098股,库藏股数为0股。\n此前,公司于2026年6月26日通过购回授权,授权总数为144,285,509股,截至目前已经于交易所累计回购4,414,000股,占授权通过时已发行股本的约0.3059%。公司确认上述回购事宜已遵守香港联交所证券上市规则及其他相关法例的规定。\n公告由公司董事张月娥签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺:9月10日回购70万股股份,总涉资约68.12万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666598562","title":"普华和顺(01358)9月10日耗资约68.12万港元回购70万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666598562","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666598562?lang=zh_cn&edition=full","pubTime":"2026-09-10 19:40","pubTimestamp":1789040435,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)公布,2026年9月10日耗资约68.12万港元回购70万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494596.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01358","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105121340","title":"普华和顺回购40.2万股股份,耗资约39.03万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1105121340","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105121340?lang=zh_cn&edition=full","pubTime":"2026-09-09 19:06","pubTimestamp":1788951970,"startTime":"0","endTime":"0","summary":"普华和顺集团公司于2026年9月9日发布翌日披露报表,宣布于当日通过香港联交所场内回购普通股402,000股,占此前已发行股份的约0.028%。每股回购价格介于港币0.97至0.98,合计动用资金390,320港元。公告显示,该等股份目前尚未注销,公司已发行股本暂保持在1,433,241,098股,库藏股为0股。公司此前于2026年6月26日获得股东大会批准回购授权,授权可回购股份总数为144,285,509股,截至本次回购,累计回购股份总数已达3,714,000股,占授权时已发行股本约0.2574%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺回购40.2万股股份,耗资约39.03万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322094","title":"普华和顺(01358)9月8日斥资4.85万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322094","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665322094?lang=zh_cn&edition=full","pubTime":"2026-09-08 19:18","pubTimestamp":1788866299,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布公告,于2026年9月8日斥资4.85万港元回购5万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493491.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01358","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144293976","title":"普华和顺回购5万股股份,总额约4.85万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144293976","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144293976?lang=zh_cn&edition=full","pubTime":"2026-09-08 19:15","pubTimestamp":1788866150,"startTime":"0","endTime":"0","summary":"2026年9月8日,普华和顺公告披露,2026年9月8日于香港联交所场内回购普通股5万股,占公司已发行股本约0.0035%。此次回购每股价格为0.97港元,合计支付约4.85万港元。公告显示,上述回购股份暂未注销,回购完成后公司已发行股本仍为14.33亿股,库藏股数为0股。公司于2026年6月26日通过购回授权,可回购总数为1.44亿股。公司确认,此次回购已获董事会正式批准,并遵守香港联交所证券上市规则及相关法律法规。公告由董事张月娥签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺回购5万股股份,总额约4.85万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164409324","title":"普华和顺回购7.8万股股份,总额约7.47万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164409324","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164409324?lang=zh_cn&edition=full","pubTime":"2026-09-07 18:46","pubTimestamp":1788778010,"startTime":"0","endTime":"0","summary":"普华和顺(01358)于2026年9月7日发布公告称,公司当日在香港联交所场内回购股份78,000股,占公司已发行股本约0.0054%,每股回购价格介乎0.955港元至0.97港元,合计付出约7.47万港元。\n公告显示,本次回购完成后,公司已发行股本维持在1,433,241,098股,当前库藏股数量为0。普华和顺于2026年6月26日获得购回授权,最多可购回144,285,509股,截至本次回购前公司已在本交易所或其他证券交易所累计回购股份3,262,000股,占该购回授权通过当日已发行股份数目的约0.2261%。公司确认已遵守香港联交所上市规则及相关法律法规;公告由董事张月娥签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺回购7.8万股股份,总额约7.47万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665316505","title":"普华和顺(01358.HK)9月7日斥资约7.47万港元回购7.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665316505","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665316505?lang=zh_cn&edition=full","pubTime":"2026-09-07 18:41","pubTimestamp":1788777710,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01358","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121166437","title":"普华和顺再度回购10万股股份,涉资约9.50万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121166437","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121166437?lang=zh_cn&edition=full","pubTime":"2026-09-04 19:32","pubTimestamp":1788521571,"startTime":"0","endTime":"0","summary":"普华和顺于2026年9月4日发布公告,披露公司继续实施股份回购并更新已发行股本变动情况。公告显示,普华和顺于2026年9月4日在香港联交所场内回购普通股100,000股,约占当日公司已发行股本的0.007%。本次回购价格为每股0.95港元,耗资合共95,000港元,折合约9.50万港元。依据公告,普华和顺可根据该授权最多购回144,285,509股,至今已在交易所累计购回3,184,000股,占授权通过当日公司已发行股本约0.2207%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺再度回购10万股股份,涉资约9.50万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664339301","title":"普华和顺(01358)9月4日斥资9.5万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339301","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664339301?lang=zh_cn&edition=full","pubTime":"2026-09-04 19:19","pubTimestamp":1788520788,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布公告,于2026年9月4日该公司斥资9.5万港元回购10万股,回购价格为每股0.95港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492248.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190639104","title":"普华和顺回购19.6万股股份,总额约18.24万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190639104","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190639104?lang=zh_cn&edition=full","pubTime":"2026-09-03 19:22","pubTimestamp":1788434528,"startTime":"0","endTime":"0","summary":"普华和顺于2026年9月3日发布翌日披露报表,公告进行股份购回。公司于当日于香港联交所场内回购普通股合计196,000股,约占该公司现有已发行股本的0.0137%,每股回购价位介乎每股0.93港元至0.935港元,合计涉资182,380港元。根据公告,普华和顺已发行股份总数于此次回购后仍为1,433,241,098股,库藏股数量为零。下一次新股发行或再出售、转让库藏股的暂止期将持续至2026年10月3日。公司声明已遵守香港联交所证券上市规则及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺回购19.6万股股份,总额约18.24万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126668335","title":"普华和顺更新8月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1126668335","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126668335?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:51","pubTimestamp":1788425472,"startTime":"0","endTime":"0","summary":"普华和顺于2026年9月3日披露的截至2026年8月31日证券变动月报显示,公司本月未发生新增股份发行及已发行股份的实际变动,股本保持稳定。据公告,截至本报告期末,普华和顺的法定/注册股本维持在5,000,000,000股普通股,面值为每股0.0001美元,总额为500,000美元。公司方面表示,所有本月涉及的交易均已获得董事会正式授权,并遵从相关法律与监管规定。公告由公司董事张月娥签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199217305","title":"普华和顺回购47.3万股股份,涉资约43.14万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1199217305","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199217305?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:45","pubTimestamp":1788349501,"startTime":"0","endTime":"0","summary":"普华和顺于2026年9月2日发布翌日报表公告,披露于当日在香港联交所场内回购股份47.3万股,占变动前已发行股本约0.033%,回购价格区间每股0.90港元至0.92港元,合计耗资约43.14万港元。公告显示,本次回购股份拟注销,变动后公司已发行股本仍为14.33亿股,且公司并无任何库藏股份。公司表示,其于2026年6月26日获得股东大会批准的购回授权可回购总数为1.44亿股。公司同时确认,已遵守香港联合交易所有限公司的证券上市规则及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺回购47.3万股股份,涉资约43.14万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819844","title":"普华和顺(01358)9月2日斥资43.14万港元回购47.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819844","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664819844?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:40","pubTimestamp":1788349244,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布公告,于2026年9月2日斥资43.14万港元回购47.3万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491157.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","01358"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pwmedtech.com","stockEarnings":[{"period":"1week","weight":-0.043},{"period":"1month","weight":-0.0825},{"period":"3month","weight":-0.1759},{"period":"6month","weight":-0.1975},{"period":"1year","weight":-0.3815},{"period":"ytd","weight":-0.297}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":-0.0505},{"period":"3month","weight":0.0042},{"period":"6month","weight":-0.0681},{"period":"1year","weight":-0.1049},{"period":"ytd","weight":-0.0585}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"普华和顺集团公司是一家主要从事医疗器械的研发(R&D)及销售业务的投资控股公司。该公司通过三个分部开展业务。输液器业务分部主要从事输液器、静脉留置针产品、胰岛素针等的研发、制造及销售。血液净化业务分部主要从事血液透析及血液净化医疗器械的研发、制造及销售。再生医用生物材料业务分部主要从事动物源性组织再生医用生物材料及人体组织修复替代产品的研发及制造。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.307692,"avgChangeRate":-0.030998},{"month":2,"riseRate":0.538462,"avgChangeRate":-0.007141},{"month":3,"riseRate":0.384615,"avgChangeRate":-0.014897},{"month":4,"riseRate":0.615385,"avgChangeRate":0.059534},{"month":5,"riseRate":0.692308,"avgChangeRate":0.040387},{"month":6,"riseRate":0.461538,"avgChangeRate":0.035491},{"month":7,"riseRate":0.615385,"avgChangeRate":0.041059},{"month":8,"riseRate":0.461538,"avgChangeRate":-0.032519},{"month":9,"riseRate":0.769231,"avgChangeRate":0.031385},{"month":10,"riseRate":0.461538,"avgChangeRate":0.012633},{"month":11,"riseRate":0.416667,"avgChangeRate":-0.038729},{"month":12,"riseRate":0.307692,"avgChangeRate":0.202103}],"exchange":"SEHK","name":"普华和顺","nameEN":"PW MEDTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"普华和顺(01358)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供普华和顺(01358)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"普华和顺,01358,普华和顺股票,普华和顺股票老虎,普华和顺股票老虎国际,普华和顺行情,普华和顺股票行情,普华和顺股价,普华和顺股市,普华和顺股票价格,普华和顺股票交易,普华和顺股票购买,普华和顺股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"普华和顺(01358)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供普华和顺(01358)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}